Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

372.40p
   
  • Change Today:
    -1.00p
  • 52 Week High: 397.00
  • 52 Week Low: 312.05
  • Currency: UK Pounds
  • Shares Issued: 9,114m
  • Volume: 31,641,273
  • Market Cap: £33,940m

Haleon Overview

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate.

1 Day Chart (31-10-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.6% 0.0%
Div Cover 2.9 n/a
Op Mrgn 17.7% n/a
ROCE 69.9%  
Latest F'cast
P/E 21.5 n/a
PEG n/a n/a
Pr/Revenue 3.0 n/a
Pr/Book 2.0  
Latest F'cast
Revenue 4.1% n/a
PBT 0.6% n/a
EPS -6.0% n/a
DPS 150.0% n/a

Haleon Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 9,545.00 1,636.00 17.90p n/a n/a n/a n/a 0.0%
31-Dec-22 10,858.00 1,618.00 18.40p 17.8 5.9 +3% 2.40p 0.7%
31-Dec-23 11,302.00 1,628.00 17.30p 18.6 n/a -6% 6.00p 1.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Haleon Company Announcements

Haleon 2024 Q3 Trading Statement 31-Oct-2024 07:00 RNS
Holding(s) in Company 29-Oct-2024 16:30 RNS
Holding(s) in Company 18-Oct-2024 15:30 RNS

Latest Haleon Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Haleon Market Data

Currency UK Pounds
Share Price 372.40p
Change Today -1.00p
% Change -0.27 %
52 Week High 397.00
52 Week Low 312.05
Volume 31,641,273
Shares Issued 9,114m
Market Cap £33,940m

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.05% above the market average4.05% above the market average4.05% above the market average4.05% above the market average4.05% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Price Trend
64.89% above the market average64.89% above the market average64.89% above the market average64.89% above the market average64.89% above the market average
88.00% above the sector average88.00% above the sector average88.00% above the sector average88.00% above the sector average88.00% above the sector average
Income Not Available
Growth
28.59% below the market average28.59% below the market average28.59% below the market average28.59% below the market average28.59% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

Haleon Dividends

  Latest Previous
  Interim Final
Ex-Div 15-Aug-24 14-Mar-24
Paid 19-Sep-24 16-May-24
Amount 2.00p 4.20p

Trades for 31-Oct-2024

Time Volume / Share Price
17:33 9,772 @ 367.82p
17:33 199,202 @ 370.52p
17:33 313 @ 365.68p
17:33 2,636 @ 365.68p
17:31 1,527,994 @ 366.79p

Haleon Key Personnel

CFO Tobias Hestler
CEO Brian McNamara

Top of Page